Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 3181 is a short (20–24 nucleotides), non-coding RNA of the microRNA (miRNA) class, which regulates gene expression at the post-transcriptional level in human cells. miRNAs are typically transcribed as part of longer primary transcripts, processed to short stem-loop precursors by Drosha, then to mature miRNAs by Dicer, and incorporated into RNA-induced silencing complexes (RISC). The mature miRNA guides the complex to complementary sequences in target mRNAs, leading to translational repression or mRNA destabilization and degradation. While the biological and pathological roles of many miRNAs are well-established, no specific functional or disease associations have been described for MicroRNA 3181 (MIR3181) to date. MIR3181 (microRNA 3181) is a specific human microRNA locus (HGNC: 38378, NCBI Gene: 100422972) with the non-coding RNA annotation. As a microRNA, it is not a receptor, enzyme, transporter, or transcription factor, but is classified under small, non-coding, regulatory RNAs that act via RNA interference pathways. There is currently no evidence that MIR3181 is a direct therapeutic target or has established drug interactions, nor is it known to be used as a biomarker in clinical settings. The general functions of miRNAs include fine-tuning of gene expression, control of cell proliferation and differentiation, and participation in development, homeostasis, and disease. Disease roles for miRNAs as a class include a wide range of human diseases (including cancer, neurodegenerative diseases, immune disorders, etc.), but MIR3181 itself has not been specifically implicated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 3181 (MIR3181).